CIK 0001644963 · Non-accelerated filer<br>Smaller reporting company
AVENUE THERAPEUTICS, INC.
Sign in to watch- Ticker
- ATXI
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 474113275
- Phone
- 781-652-4500
- Business address
- 1111 KANE CONCOURSE, SUITE 301, BAY HARBOR ISLANDS, FL, 33154
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-02 | Fortress Biotech, Inc. 10% owner | Grant or award | +111,209 | 439,733 | ||
| 2025-03-31 | Fortress Biotech, Inc. 10% owner | Grant or award | +33,724 | 328,524 | ||
| 2024-12-02 | Herskowitz Neil Director | Sale | −23 | $2.00 | $46 | 97 |
| 2024-11-05 | KRANZLER JAY D Director | Sale | −61 | $2.24 | $137 | 559 |
| 2024-09-30 | KRANZLER JAY D Director | Purchase | +497 | $2.50 | $1K | 620 |
| 2024-09-27 | KRANZLER JAY D Director | Purchase | +3 | $2.40 | $7 | 123 |
| 2024-09-23 | ROSENWALD LINDSAY A MD Director | Grant or award · Employee stock option (right to buy) | +30,000 | 30,000 | ||
| 2024-09-23 | Herskowitz Neil Director | Grant or award · Employee stock option (right to buy) | +30,000 | 30,000 | ||
| 2024-09-23 | Oltmans Curtis Gale Director | Grant or award · Employee stock option (right to buy) | +30,000 | 30,000 | ||
| 2024-09-23 | MacLean Alexandra Chief Executive Officer | Grant or award | +170,000 | 170,000 | ||
| 2024-09-23 | KRANZLER JAY D Director | Grant or award · Employee stock option (right to buy) | +30,000 | 30,000 | ||
| 2024-09-23 | Jin David Interim PFO and COO | Grant or award | +65,000 | 65,000 | ||
| 2024-09-23 | Charles Faith L. Director | Grant or award · Employee stock option (right to buy) | +30,000 | 30,000 | ||
| 2024-04-16 | Fortress Biotech, Inc. 10% owner | Grant or award | +413,507 | 3,547,393 | ||
| 2024-01-02 | Fortress Biotech, Inc. 10% owner | Grant or award | +2,101,496 | 3,133,886 | ||
| 2023-12-11 | Davidow Robert L 10% owner | Sale | −264,000 | $0.14 | $37K | 681,000 |
| 2023-12-11 | Davidow Robert L 10% owner | Sale | −18,000 | $0.15 | $3K | 22,000 |
| 2023-12-11 | Davidow Robert L 10% owner | Sale | −61,000 | $0.14 | $9K | 74,000 |
| 2023-12-11 | Davidow Robert L 10% owner | Sale | −126,000 | $0.14 | $18K | 215,800 |
| 2023-12-11 | Davidow Robert L 10% owner | Sale | −128,000 | $0.14 | $18K | 147,000 |
Page 1 of 6 · 101 trades